What Is the Best Viral Conjunctivitis Treatment?

Viral conjunctivitis is the most common form of infectious conjunctivitis, and in most cases it clears on its own without specific antiviral medication. Treatment is supportive: cold compresses, artificial tears, and time. That sounds frustratingly passive when your eyes are red, swollen, and streaming, but the honest reality is that no antiviral drug has been approved specifically for the most frequent culprit, adenovirus. Research into more targeted therapies is advancing, though, and certain complications do warrant active treatment beyond the basics.

What Supportive Care Actually Involves

“Supportive care” can feel like a euphemism for “we’re not going to do anything,” but there are concrete steps that make the illness more bearable and help prevent spreading it. Cool compresses over closed eyelids reduce swelling and soothe the gritty, burning sensation. Preservative-free artificial tears help dilute viral particles on the eye surface and relieve dryness. Over-the-counter antihistamine eye drops can help if itching is a major complaint, though itching is more characteristic of allergic conjunctivitis than viral. Oral pain relievers like ibuprofen or acetaminophen can take the edge off if the discomfort is significant.

One thing that matters as much as symptom relief is not making things worse. Contact lenses should come out immediately and stay out until the infection resolves. Any eye makeup used around the time symptoms started should be discarded. Sharing towels, pillowcases, or eye drops with others in the household is a reliable way to spread the virus. Frequent handwashing, especially after touching the face, is the single most effective way to prevent transmission. Adenovirus, the most common viral cause, can survive on surfaces for weeks, which is why outbreaks spread so efficiently through schools, military barracks, and medical offices.

Most cases of adenoviral conjunctivitis resolve within one to three weeks. Acute hemorrhagic conjunctivitis caused by enteroviruses like coxsackievirus A24 tends to be shorter, with symptoms often clearing within five to six days and full resolution in about ten days without treatment.¹ An outbreak investigation confirmed that most cases resolved within five to six days, with no serious complications within a month of follow-up.²

How Doctors Distinguish Viral From Bacterial Conjunctivitis

The distinction matters because bacterial conjunctivitis responds to antibiotic drops and viral conjunctivitis does not. Unfortunately, telling them apart by eye exam alone is harder than you might expect. Both can produce red, watery, swollen eyes. A few clinical clues tilt the odds. Eyelids glued shut with thick discharge in the morning suggest bacteria. Watery rather than purulent discharge, involvement of both eyes in sequence, and a tender swollen lymph node just in front of the ear (preauricular lymphadenopathy) lean toward a viral cause.

Research has tried to formalize these clues. One cohort study found that the best diagnostic combination was whether the patient woke with glued-shut eyes, whether itching was present, and whether they had a history of previous conjunctivitis. Glued eyes pushed the odds toward bacteria, while itching and prior episodes pushed them away from it. Even this optimized combination, though, was only moderately accurate.³ History and physical examination alone are sometimes insufficient for a correct diagnosis, and lab testing can play a role in identifying the specific pathogen.⁴

A rapid in-office test called AdenoPlus can detect adenovirus on a conjunctival swab in about ten minutes. It is highly specific, meaning a positive result is very reliable, but its sensitivity has been disappointing. One study found it caught only half of adenovirus cases confirmed by more sensitive PCR testing, meaning a negative result does not rule out the virus.⁵ In practice, many doctors treat based on the clinical picture rather than waiting for test results, which contributes to the next problem.

Why Antibiotics Keep Getting Prescribed Anyway

Despite viral conjunctivitis being the most common cause of infectious conjunctivitis, antibiotic eye drops are prescribed far more often than they should be.⁶ A cross-sectional study at a specialist eye hospital found that over half of patients with acute conjunctivitis received antibiotics, and among those prescriptions, roughly a third were judged inappropriate.⁷ The drivers are understandable: diagnostic uncertainty, patient expectations for a prescription, and the worry that missing a bacterial case could lead to complications. But unnecessary antibiotics waste money, risk side effects like allergic reactions, and contribute to antimicrobial resistance.

If you visit a doctor for conjunctivitis and are told to wait it out with supportive care, that is not dismissiveness. It reflects what the evidence supports. Antibiotic drops do nothing against adenovirus or other viral causes. If your symptoms strongly suggest bacteria, or if testing confirms it, antibiotics are appropriate. Otherwise, they are not just unhelpful but actively counterproductive at a population level.

Povidone-Iodine and Combination Drops

The most promising line of research for an actual treatment against adenoviral conjunctivitis involves povidone-iodine, a broad-spectrum antiseptic that has been used in surgery and wound care for decades. Povidone-iodine can kill adenovirus on the eye surface, and when combined with a steroid to control inflammation, the results in clinical trials have been encouraging.

A controlled phase 2 trial tested a combination of povidone-iodine and dexamethasone against each component alone and against placebo. By day six, about a third of patients on the combination had clinical resolution, compared with roughly a tenth on placebo. Viral eradication was also faster: by day six, nearly 80% of patients on the combination had no detectable adenovirus, compared with about 57% on placebo.⁸ An earlier pilot study of the same combination found clinical resolution in most eyes by day three or four, with elimination of infectious virus by day four or five.⁹

Povidone-iodine alone, without the steroid component, has also shown benefit. A study of 2% povidone-iodine eye drops found that after seven days of treatment, discharge decreased in over 90% of patients and injection (visible redness from dilated blood vessels) improved at a similar rate.¹⁰ Still, no formulation of povidone-iodine has yet received regulatory approval specifically for adenoviral conjunctivitis. Researchers have noted that this gap between clinical promise and approved treatment options is a significant unmet need in ophthalmology.¹¹

Subepithelial Infiltrates and When Steroids Enter the Picture

The most annoying complication of adenoviral conjunctivitis is something called subepithelial infiltrates, or SEIs. These are small, hazy spots that form in the cornea days to weeks after the initial infection. They are not infectious deposits of virus but immune reactions: the body’s inflammatory response leaves behind cloudy patches that can blur vision and cause glare, sometimes for months. In one study, more than 60% of patients treated with artificial tears alone had developed SEIs by day 21.¹²

Corticosteroid eye drops are the standard treatment for SEIs and for severe inflammation during acute adenoviral conjunctivitis. That same study found that patients on topical corticosteroids had the shortest time to symptom resolution (about nine and a half days on average) compared with about thirteen days for those on artificial tears alone. The corticosteroid group also had fewer SEIs at three weeks. Cyclosporine eye drops performed in between, offering some benefit over tears alone.¹³

The catch with corticosteroids is that they carry real risks for the eye. Prolonged use can raise intraocular pressure, potentially leading to steroid-induced glaucoma. One study comparing dexamethasone to tacrolimus for SEIs found that about 16% of patients on dexamethasone developed a significant rise in eye pressure.¹⁴ This is why doctors prescribe steroids cautiously, typically for a limited course with gradual tapering, and monitor pressure along the way.

The problem is that some patients’ SEIs flare back up every time steroids are tapered. This creates a frustrating cycle of improvement and recurrence. Cyclosporine eye drops have emerged as a steroid-sparing alternative for these cases. In one series, all eyes that had been unable to taper off corticosteroids were successfully maintained on cyclosporine drops once daily or less, with follow-up extending over a year on average.¹⁵ Tacrolimus, a related immunosuppressant, has shown similar promise. A comparative study found both tacrolimus and cyclosporine significantly reduced SEIs over six months, with tacrolimus showing a faster response at three months.¹⁶ A combined povidone-iodine and dexamethasone preparation has also been tested specifically for SEIs, with significant improvement in symptoms and visual acuity within two weeks.¹⁷

Pseudomembranes and Severe Cases

Most people with viral conjunctivitis never need to worry about anything beyond red, watery eyes for a week or two. But a minority of patients, particularly with certain adenovirus serotypes, develop severe inflammation that produces pseudomembranes: sheets of fibrin and inflammatory cells that coat the inside of the eyelids and can stick to the eye surface. In its worst form, this inflammatory response can lead to scarring between the eyelid and the eyeball, a condition called symblepharon that causes longer-term problems.¹⁸

The traditional approach to pseudomembranes has been to physically peel them off the eyelid surface, sometimes repeatedly. However, the evidence base for debridement is limited, and case reports have shown that conservative management with topical lubricants and corticosteroids, without debridement, can produce good outcomes.¹⁹ The decision about whether to debride pseudomembranes is one your ophthalmologist should make based on the specific clinical picture. If you are told that the membranes will be left in place and managed with drops, that is a legitimate approach, not neglect.

When the Virus Is Herpes, Treatment Changes Entirely

Not all viral conjunctivitis is adenoviral. Herpes simplex virus (HSV) is a less common but more consequential cause. Unlike adenoviral conjunctivitis, herpes eye infections can be treated with antiviral medication and generally should be, because untreated herpes can damage the cornea and threaten vision. Topical ganciclovir has been shown to be as safe and effective as the older standard acyclovir for herpes-related corneal disease.²⁰

Herpes conjunctivitis typically affects only one eye, and the presence of skin vesicles around the eyelids or a dendritic (branching) pattern on the cornea, visible with a slit lamp, are strong clues. This distinction is one reason eye doctors do not simply lump all “pink eye” together. A herpes infection mistakenly treated with steroid drops alone, without an antiviral, can worsen dramatically. If your conjunctivitis is unilateral, painful, and accompanied by blister-like lesions on the skin, get it evaluated promptly rather than assuming it will clear on its own.

Conjunctivitis as a Symptom of COVID-19

During the pandemic, attention turned to whether SARS-CoV-2 could cause conjunctivitis. A pooled analysis estimated that roughly 11% of patients with COVID-19 had some form of ocular involvement, with conjunctivitis being the most common presentation.²¹ In rare cases, conjunctivitis was the only symptom of an active COVID-19 infection. One case-control study found that about 3% of COVID-positive patients had conjunctivitis, and three patients in that study had conjunctivitis as their sole symptom during the entire course of infection.²²

COVID-related conjunctivitis follows the same self-limiting course as other viral conjunctivitis, and treatment is supportive.²³ The practical takeaway is that isolated conjunctivitis during a period of high respiratory virus circulation is worth considering as a possible systemic infection, especially if the patient later develops respiratory symptoms. For clinicians, a unilateral conjunctivitis with no obvious cause during an active outbreak warrants some index of suspicion.

The Workplace and Financial Cost of Pink Eye

Viral conjunctivitis tends to get treated as a minor nuisance, but it carries real economic weight. Healthcare workers with adenoviral conjunctivitis may be furloughed from clinical duties to prevent nosocomial outbreaks, and when the virus spreads through a medical center, the costs from lost productivity and containment measures add up quickly.²⁴

A study of commercially insured patients in the United States found that people with conjunctivitis were about twice as likely to miss work compared with matched controls. The work-loss costs were roughly double, driven almost entirely by medically related absences rather than short-term disability.²⁵ For an individual, missing a day or two feels manageable. Multiplied across the millions of conjunctivitis cases per year in the U.S., the aggregate productivity loss is substantial, which is part of the motivation behind developing treatments that could shorten the infectious period.

Herbal Remedies and Home Treatments

If you search for viral conjunctivitis treatments online, you will quickly encounter suggestions for chamomile tea compresses, eyebright (Euphrasia), aloe vera, and various other plant-based remedies. Some of these have shown anti-inflammatory activity in lab settings, which is where the enthusiasm comes from. The problem is that human clinical evidence is very limited, and applying herbal preparations directly to an infected eye carries genuine risk. Absolute sterility is essentially impossible to achieve in a home kitchen, and contaminated herbal preparations can introduce bacteria into an already inflamed eye. Allergic reactions to plant compounds are also common enough to be a concern, and an allergic reaction in an eye that is already red and swollen from a viral infection is not something you want to add to the mix.

A systematic review and meta-analysis of Ayurvedic treatments for conjunctivitis did find some evidence of symptom improvement across a handful of small trials, with reductions in itching, pain, and congestion compared to non-Ayurvedic comparators.²⁶ But the trials were small, the comparators varied, and the findings are far from the level of confidence needed to change clinical recommendations. Cool, clean compresses made with plain water achieve the same soothing goal without the contamination risk. If you want to hold something comforting over your eyes, a clean washcloth soaked in cool water and wrung out is the safest option.

When to See a Doctor Rather Than Waiting It Out

Most viral conjunctivitis does not need a doctor visit. But several situations change the calculus. Vision changes, particularly blurriness that persists after blinking away discharge, may indicate corneal involvement from SEIs or a herpetic infection. Severe eye pain, as opposed to the mild irritation and foreign-body sensation typical of routine viral conjunctivitis, deserves evaluation. A single eye affected with vesicular skin lesions raises the possibility of herpes. Symptoms lasting more than two to three weeks without improvement suggest either a different diagnosis or the development of complications. Contact lens wearers with red eyes should always be seen, because the combination of contact lenses and an infected eye surface increases the risk of corneal ulceration from secondary bacterial infection.

Newborns with conjunctivitis are a separate category entirely. Neonatal conjunctivitis can be caused by sexually transmitted infections acquired during birth and requires urgent evaluation. The “wait and see” approach that works for most adults does not apply to infants in the first month of life.

Immunocompromised patients, including those on chemotherapy, long-term systemic steroids, or medications that suppress the immune system, may have more prolonged or severe courses of viral conjunctivitis. For these individuals, early evaluation is reasonable even if symptoms seem mild, because their immune response may not contain the virus as effectively.